PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OMGA vs. CRVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OMGA and CRVO is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

OMGA vs. CRVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Omega Therapeutics, Inc. (OMGA) and CervoMed Inc. (CRVO). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-85.56%
-87.14%
OMGA
CRVO

Key characteristics

Sharpe Ratio

OMGA:

-0.65

CRVO:

-0.66

Sortino Ratio

OMGA:

-1.76

CRVO:

-0.60

Omega Ratio

OMGA:

0.77

CRVO:

0.90

Calmar Ratio

OMGA:

-0.95

CRVO:

-0.84

Martin Ratio

OMGA:

-1.50

CRVO:

-1.67

Ulcer Index

OMGA:

63.26%

CRVO:

50.64%

Daily Std Dev

OMGA:

146.63%

CRVO:

128.55%

Max Drawdown

OMGA:

-99.63%

CRVO:

-99.99%

Current Drawdown

OMGA:

-99.25%

CRVO:

-99.99%

Fundamentals

Market Cap

OMGA:

$10.70M

CRVO:

$17.58M

EPS

OMGA:

-$1.32

CRVO:

-$2.17

Total Revenue (TTM)

OMGA:

$7.11M

CRVO:

$5.64M

Gross Profit (TTM)

OMGA:

-$4.05M

CRVO:

$2.82M

EBITDA (TTM)

OMGA:

-$50.70M

CRVO:

-$10.99M

Returns By Period

In the year-to-date period, OMGA achieves a -70.43% return, which is significantly lower than CRVO's -6.41% return.


OMGA

YTD

-70.43%

1M

-63.07%

6M

-85.59%

1Y

-94.49%

5Y*

N/A

10Y*

N/A

CRVO

YTD

-6.41%

1M

2.82%

6M

-87.15%

1Y

-85.20%

5Y*

-41.23%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OMGA vs. CRVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OMGA
The Risk-Adjusted Performance Rank of OMGA is 55
Overall Rank
The Sharpe Ratio Rank of OMGA is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of OMGA is 33
Sortino Ratio Rank
The Omega Ratio Rank of OMGA is 44
Omega Ratio Rank
The Calmar Ratio Rank of OMGA is 11
Calmar Ratio Rank
The Martin Ratio Rank of OMGA is 55
Martin Ratio Rank

CRVO
The Risk-Adjusted Performance Rank of CRVO is 1111
Overall Rank
The Sharpe Ratio Rank of CRVO is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of CRVO is 1818
Sortino Ratio Rank
The Omega Ratio Rank of CRVO is 1616
Omega Ratio Rank
The Calmar Ratio Rank of CRVO is 44
Calmar Ratio Rank
The Martin Ratio Rank of CRVO is 33
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OMGA vs. CRVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Omega Therapeutics, Inc. (OMGA) and CervoMed Inc. (CRVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OMGA, currently valued at -0.65, compared to the broader market-2.000.002.004.00-0.65-0.66
The chart of Sortino ratio for OMGA, currently valued at -1.76, compared to the broader market-6.00-4.00-2.000.002.004.006.00-1.76-0.60
The chart of Omega ratio for OMGA, currently valued at 0.77, compared to the broader market0.501.001.502.000.770.90
The chart of Calmar ratio for OMGA, currently valued at -0.95, compared to the broader market0.002.004.006.00-0.95-0.88
The chart of Martin ratio for OMGA, currently valued at -1.50, compared to the broader market0.0010.0020.0030.00-1.50-1.67
OMGA
CRVO

The current OMGA Sharpe Ratio is -0.65, which is comparable to the CRVO Sharpe Ratio of -0.66. The chart below compares the historical Sharpe Ratios of OMGA and CRVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
-0.65
-0.66
OMGA
CRVO

Dividends

OMGA vs. CRVO - Dividend Comparison

Neither OMGA nor CRVO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OMGA vs. CRVO - Drawdown Comparison

The maximum OMGA drawdown since its inception was -99.63%, roughly equal to the maximum CRVO drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for OMGA and CRVO. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%SeptemberOctoberNovemberDecember2025February
-99.25%
-95.18%
OMGA
CRVO

Volatility

OMGA vs. CRVO - Volatility Comparison

Omega Therapeutics, Inc. (OMGA) has a higher volatility of 139.42% compared to CervoMed Inc. (CRVO) at 9.71%. This indicates that OMGA's price experiences larger fluctuations and is considered to be riskier than CRVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
139.42%
9.71%
OMGA
CRVO

Financials

OMGA vs. CRVO - Financials Comparison

This section allows you to compare key financial metrics between Omega Therapeutics, Inc. and CervoMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab